Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$25.89 - $29.73 $35,003 - $40,194
-1,352 Reduced 12.71%
9,283 $257,000
Q4 2023

Feb 08, 2024

SELL
$26.13 - $33.94 $67,938 - $88,244
-2,600 Reduced 19.64%
10,635 $306,000
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $245,488 - $286,951
-7,650 Reduced 36.63%
13,235 $439,000
Q2 2023

Jul 28, 2023

SELL
$36.12 - $41.79 $169,764 - $196,413
-4,700 Reduced 18.37%
20,885 $766,000
Q1 2023

Apr 20, 2023

BUY
$39.39 - $51.28 $5,908 - $7,692
150 Added 0.59%
25,585 $1.04 Million
Q4 2022

Jan 17, 2023

BUY
$41.75 - $54.5 $170,757 - $222,905
4,090 Added 19.16%
25,435 $0
Q3 2022

Oct 11, 2022

SELL
$43.76 - $53.42 $19,692 - $24,039
-450 Reduced 2.06%
21,345 $934,000
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $204,732 - $242,748
4,400 Added 25.29%
21,795 $1.14 Million
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $331,458 - $410,719
-7,245 Reduced 29.4%
17,395 $901,000
Q4 2021

Feb 03, 2022

BUY
$41.32 - $61.25 $776,444 - $1.15 Million
18,791 Added 321.27%
24,640 $1.46 Million
Q3 2021

Nov 04, 2021

BUY
$39.25 - $50.42 $12,795 - $16,436
326 Added 5.9%
5,849 $252,000
Q2 2021

Aug 02, 2021

SELL
$35.91 - $40.68 $3,986 - $4,515
-111 Reduced 1.97%
5,523 $216,000
Q4 2020

Feb 01, 2021

SELL
$33.47 - $42.56 $17,839 - $22,684
-533 Reduced 8.64%
5,634 $207,000
Q3 2020

Nov 03, 2020

BUY
$31.75 - $37.25 $195,802 - $229,720
6,167 New
6,167 $226,000
Q2 2020

Aug 06, 2020

SELL
$30.12 - $36.54 $226,562 - $274,853
-7,522 Closed
0 $0
Q1 2020

May 05, 2020

BUY
$27.03 - $38.62 $63,493 - $90,718
2,349 Added 45.41%
7,522 $246,000
Q4 2019

Feb 06, 2020

BUY
$32.92 - $37.36 $170,295 - $193,263
5,173 New
5,173 $203,000
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $176,615 - $201,361
-4,591 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$34.47 - $41.81 $158,251 - $191,949
4,591 New
4,591 $202,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $162B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Novare Capital Management LLC Portfolio

Follow Novare Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novare Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Novare Capital Management LLC with notifications on news.